Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

CDK4-specific antisense oligodeoxynucleotides for inhibition of tumors

July 1, 1999

Coulter, SmithKline Beecham file BLA for Bexxar

July 1, 1999

5-Halo- or nitrate-substituted paclitaxels under study at Bristol-Myers Squibb

July 1, 1999

Alza's Doxil approved in U.S. for treatment of refractory ovarian cancer

July 1, 1999

Valentis moves IL-2 gene therapy to phase II

July 1, 1999

InKine files two patent applications relating to thrombospondin receptor

July 1, 1999

NCI initiates phase I trials with patient-specific cancer vaccines

July 1, 1999

Introgen Therapeutics receives milestone payment from RPR

July 1, 1999

Aronex reports responses in phase II trial of Atragen as treatment of NHL

June 30, 1999

New compounds from Merck inhibit posttranslational farnesylation of proteins

June 30, 1999

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...